Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 8 Gynecologic 3 Tumor-Agnostic 2 Other solid neoplasm 2 Genitourinary 2 Gastrointestinal 2 Sarcoma 1 Head & Neck 1 Endocrine 1 CNS 1 Breast 1

Conditions

Osteosarcoma 1 Leiomyosarcoma 1

Interventions

Radiotherapy 221 Cyclophosphamide 211 Doxorubicin 210 Temozolomide 182 Ifosfamide 121 Filgrastim 111 Imatinib Mesylate 104 Etoposide 101 Vincristine 92 Gemcitabine 89 Bevacizumab 83 Magnetic Resonance Spectroscopy 81 Irinotecan 79 pembrolizumab 75 Radiation 70 Carboplatin 65 Methotrexate 62 pazopanib 61 Nivolumab 58 Cisplatin 58 fludarabine phosphate 57 Surgical Procedures, Operative 57 Peripheral Blood Stem Cell Transplantation 57 Specimen Handling 56 Trabectedin 52 Docetaxel 50 Biopsy 50 Busulfan 49 Melphalan 46 Paclitaxel 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

berzosertib × Sarcoma × Clear all

NCT03718091 2023-07-07

M6620 (VX-970) in Selected Solid Tumors

Massachusetts General Hospital

Phase 2 Completed

30 enrolled 15 charts

Leiomyosarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡